Skip to main content

You're visiting from outside the EU. Switch to the US version to see local pricing and tax details in USD.

Switch to US ($)
Contact +33 (0)3 90 20 54 70

🚀 Special Offer🚀Get 25% off on your bioreagent online order (except Micelles and Nanodiscs), with the code: PROTEOSHOP25

📢 New ! Accelerate your Antibody Development with Ready-to-use Stable Cell Pools

Explore Now
  • Wide range of unique reagents
  • Free Shipping
    Free shipping in EU on Orders > €500
  • Fast worldwide delivery
    Fast worldwide delivery
Nycodenz AG® Nycodenz AG® XtenCHO ™ Race Starter kit XtenCHO ™ Race Starter kit
View all Products

Urelumab Biosimilar – Anti-TNFRSF9, CD137 mAb – Research Grade

Reference:
Product Image
SDS-PAGE for Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb
Product Image
SDS-PAGE for Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb
Size

100ug, 1MG
Isotype

IgG4, kappa
Brand

ProteoGenix
Product type

Primary Antibodies
Clonality

Monoclonal Antibody
Expression system

Mammalian cells
Applications

Elisa, WB
Tags:
Specification
Description
Documents
QC & Validation Data2
Reviews
Product nameUrelumab Biosimilar - Anti-TNFRSF9, CD137 mAb - Research Grade
SourceCAS 934823-49-1
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsUrelumab,BMS-663513,TNFRSF9, CD137 ,anti-TNFRSF9, CD137
ReferencePX-TA1265
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG4-kappa
ClonalityMonoclonal Antibody

Description of Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb - Research Grade

General information on Anti-TNFRSF9/CD137 [Homo sapiens] (Urelumab) Monoclonal Antibody

Urelumab is a human antibody targeting CD137. Urelumab has been investigated for the treatment of Leukemia, Multiple Myeloma, Malignant Tumors, Cancer – Solid Tumors and B-Cell Non-Hodgkin’s Lymphoma.

Datasheet Download
MSDS Download

SDS-PAGE for Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb

Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb, on SDS-PAGE under reducing and non-reducing conditions. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

Immobilized CD137 Recombinant Protein (cat. No.PX-P4107) at 0.5µg/mL (100µL/well) can bind to Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb (cat. No.PX-TA1265) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Urelumab Biosimilar – Anti-TNFRSF9, CD137 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Human CD137–TNFRSF9-4–1BB recombinant protein
Antigen

Human CD137–TNFRSF9-4–1BB recombinant protein

PX-P4059 210€
View product
CD137 Recombinant Protein
Antigen

CD137 Recombinant Protein

PX-P4107 420€
View product
Urelumab ELISA Kit
ELISA

Urelumab ELISA Kit

KPTX241 1179€
View product

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.

    Cart (0 Items)

    Your cart is currently empty.

    View Products